These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37830930)

  • 1. Successful treatment of experimental murine vulvovaginal candidiasis with gentian violet.
    Bonfim AP; Sakita KM; Faria DR; Arita GS; Rodrigues-Vendramini FA; Capoci IR; Braga AG; Mosca VA; Junior AG; Kioshima ÉS; Bonfim-Mendonça PS; Svidzinski TI
    Future Microbiol; 2023 Nov; 18():1137-1146. PubMed ID: 37830930
    [No Abstract]   [Full Text] [Related]  

  • 2. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
    Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
    BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intravaginal gentian violet for acute vaginal candidiasis treated with a single dose oral fluconazole: a randomised controlled trial.
    Chayachinda C; Thamkhantho M; Ngamsakulrungroj P; Leeyaphan C; Tulyaprawat O
    J Obstet Gynaecol; 2022 Aug; 42(6):2190-2196. PubMed ID: 35253598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis.
    Zhang X; Li T; Chen X; Wang S; Liu Z
    BMC Microbiol; 2018 Oct; 18(1):166. PubMed ID: 30359236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of resistance and sensitivity of 1 200 strains of vulvovaginal candidiasis in China to five common antifungal drugs].
    Fan LY; Liu ZH; Bai XN; Zong X
    Zhonghua Fu Chan Ke Za Zhi; 2022 Aug; 57(8):601-607. PubMed ID: 36008287
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma-based strategy for inhibiting Candida albicans growth and CaMCA1 gene expression in vitro and reducing fungal pathogenicity in a murine model of vulvovaginal candidiasis.
    Ebrahimi-Shaghaghi F; Atyabi SM; Razzaghi-Abyaneh M
    Med Mycol; 2021 Dec; 60(1):. PubMed ID: 34694384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of tea tree oil 5%, tea tree oil 10%, and nystatin inhibition zones against vaginal Candida isolates in pregnancy.
    Ervianti E; Damayanti ; Purnamasari I; Astari L; Prasetyo B; Endraswari PD; Utomo B; Fitriani EW; Indramaya DM; Listiawan MY; Sigit Prakoeswa CR
    J Infect Dev Ctries; 2023 Mar; 17(3):353-358. PubMed ID: 37023426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
    Choukri F; Benderdouche M; Sednaoui P
    J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Preclinical Study of Galloylquinic Acid Compounds from
    Al-Madboly LA; Abd El-Salam MA; Bastos JK; El-Shorbagy SH; El-Morsi RM
    Microbiol Spectr; 2022 Oct; 10(5):e0272421. PubMed ID: 35972130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
    Gao M; Wang H; Zhu L
    Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes of local vaginal immune regulation in rats infected with vulvovaginal candidiasis].
    Chen X; Li T; Wang FJ; Shang CG; Zhang X; Bai HH; Liu ZH
    Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):330-337. PubMed ID: 31154715
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis.
    Shi Y; Zhu Y; Fan S; Liu X; Liang Y; Shan Y
    BMC Infect Dis; 2020 Apr; 20(1):287. PubMed ID: 32393342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis.
    Fan SR; Liu XP
    Mycoses; 2011 Nov; 54(6):501-5. PubMed ID: 20406393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species.
    Martins HP; da Silva MC; Paiva LC; Svidzinski TI; Consolaro ME
    Acta Derm Venereol; 2012 Jan; 92(1):78-82. PubMed ID: 21918792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal efficacy of atorvastatin-containing emulgel in the treatment of oral and vulvovaginal candidiasis.
    de Oliveira Neto AS; Souza ILA; Amorim MES; de Freitas Souza T; Rocha VN; do Couto RO; Fabri RL; de Freitas Araújo MG
    Med Mycol; 2021 May; 59(5):476-485. PubMed ID: 32823281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.
    Goswami D; Goswami R; Banerjee U; Dadhwal V; Miglani S; Lattif AA; Kochupillai N
    J Infect; 2006 Feb; 52(2):111-7. PubMed ID: 15908007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ROS mediated anticandidal efficacy of 3-Bromopyruvate prevents vulvovaginal candidiasis in mice model.
    Jothi R; Hong ST; Enkhtsatsral M; Pandian SK; Gowrishankar S
    PLoS One; 2023; 18(12):e0295922. PubMed ID: 38153954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vulvovaginal candidiasis in Iranian women: Molecular identification and antifungal susceptibility pattern.
    Khaksar Baniasadi A; Ayatollahi Mosavi SA; Sharifi I; Bamorovat M; Salari S; Ahmadi A; Amanizadeh A; Agha Kuchak Afshari S
    J Obstet Gynaecol Res; 2022 Dec; 48(12):3292-3303. PubMed ID: 36184563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China.
    Kan S; Song N; Pang Q; Mei H; Zheng H; Li D; Cui F; Lv G; An R; Li P; Xiong Z; Fan S; Zhang M; Chen Y; Qiao Q; Liang X; Cui M; Li D; Liao Q; Li X; Liu W
    Mycopathologia; 2023 Apr; 188(1-2):99-109. PubMed ID: 36378354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.